We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sequenom to Begin Clinical Assessment of Noninvasive Screening Technology for Down Syndrome

News   Jan 24, 2008

 
Sequenom to Begin Clinical Assessment of Noninvasive Screening Technology for Down Syndrome
 
 
 

RELATED ARTICLES

Drug Targets Early Instigator of Alzheimer's Disease

News

Therapeutic efforts to target "plaques and tangles", considered classic hallmarks of Alzheimer's disease, have previously met with dispiriting failure. Now researchers are exploring a drug called "DYR219" – its strength lies in the fact that it can target both plaques and tangles.

READ MORE

World-first: Genetically Modified Miniature Human Livers Are Grown in the Laboratory

News

Researchers are the first to grow genetically modified miniature human livers in the laboratory, to emulate human liver disease progression and test therapeutics.

READ MORE

Blinking Eye-on-a-Chip Helps Test Drug Candidates

News

An eye-on-a-chip, complete with a blinking eyelid, is helping scientists and drug developers to improve their understanding and treatment of dry eye disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE